SOUTH SAN FRANCISCO, Calif.--Axys Pharmaceuticals and Signal Pharmaceuticals announced they have entered into a collaboration for the accelerated discovery of compounds that interact with specific cell signaling pathways. Signal will use its proprietary assays to screen small molecules derived from Axys's compound libraries. Specific molecular targets were not disclosed.